DUBLIN (BUSINESS WIRE) The "China Pharmaceutical Companies and Drugs Pipeline Insight 2023" drug pipelines has been added to ResearchAndMarkets.com's offering.Chinese drugs makers have advanced significantly in the global pharmaceutical market over the previous two decades, becoming reliable partners for drug deve.
/PRNewswire/ The "China Cancer Antibodies Market Trends & Clinical Trials Insight 2023" report has been added to ResearchAndMarkets.com s offering. The.
The development of oral biologics and early aggressive treatment to change the course of the disease are among the possibilities, according to Andrew Blauvelt, MD, MBA.
Qitan Technology completed a $101 million Series C round to support its commercialized nanopore devices. Takeda was approved to launch Exkivity (mobocertinib) in China.